Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo
about
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsHexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancerDesign of virus-based nanomaterials for medicine, biotechnology, and energy.Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics.Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5.Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.
P2860
Q26776553-4A9C227F-AED2-448C-88F8-7B9A9C6897A9Q26782083-485490D5-2B9E-4D4A-B0EC-D374F3644083Q35096275-5CC2D5F8-EBD4-4389-B421-EBA0BF3F39FDQ37346447-2B13BE43-8C0F-4C29-A9AB-6E297BE9D181Q38297124-10EB845C-78C1-46DA-8DB4-3287928DFAD2Q40103248-B4AE1E23-1863-4751-80AD-88057231CE97Q47547452-D247E03A-607C-4C29-973F-FC54CDE9273A
P2860
Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@ast
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@en
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@nl
type
label
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@ast
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@en
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@nl
prefLabel
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@ast
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@en
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@nl
P2093
P2860
P1433
P1476
Traceless bioresponsive shield ...... capacity in vitro and in vivo
@en
P2093
Andrea Hoffmeister
Florian Kreppel
Jan-Michael Prill
Karel Ulbrich
Noemi Pasquarelli
Stefan Kochanek
Tatjana Engler
Vladimír Subr
P2860
P304
P356
10.1371/JOURNAL.PONE.0082716
P407
P577
2014-01-01T00:00:00Z